• Longbio Pharma updated its board and committee lineup on Aug. 31, 2026, naming Liu Heng as chairman.
• Executive directors: Liu Heng, Sun Naichao, Xie Ming; non-executive directors: Lin Jian, Gu Qin, Xue Di.
• Independent non-executive directors: Xiao Yaoxi, Ruan Tianshi, Yang Chun, Zhou Guofang.
• Audit committee chaired by Xiao Yaoxi; members include Lin Jian, Ruan Tianshi.
• Remuneration committee chaired by Yang Chun; nomination committee chaired by Liu Heng.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longbio Pharma (Suzhou) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12308455), on August 31, 2026, and is solely responsible for the information contained therein.